动脉高血压患者的低血症:病理生理学和管理
Marcin Adamczak1, Stanisław Surma1, Andrzej Więcek1
1Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland.
Archives of medical science : AMS
|December 7, 2023
概括
低血症,低水平,在高血压患者中很常见,增加疾病风险. 本综述涵盖了其原因,症状和管理,强调谨慎治疗以避免并发症.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 是一种关键的细胞外离子,调节液体平衡.
- 低血量 (血<135 mmol/l) 恶化慢性疾病的预后.
- 动脉高血压增加了1.5倍的低血风险.
研究的目的:
- 审查动脉高血压中低血症的病理生理学.
- 讨论这个患者群体中低血症的当前管理策略.
主要方法:
- 文献综述侧重于平衡,低血和动脉高血压.
- 分析糖氨基甘油和内皮糖在调节中的作用.
- 讨论导尿剂诱导的低血症.
主要成果:
- 低血症的症状源于中枢神经系统细胞的胀.
- thiazide 利尿剂是高血压患者低血的常见原因.
- 治疗需要仔细考虑严重程度,持续时间和症状.
结论:
- 低血对患有动脉高血压的患者构成重大风险.
- 管理需要一个细微的方法,以避免快速纠正并发症,如透性脱髓化综合征.
相关概念视频
Antihypertensive Drugs: Action of Diuretics
786
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
786
Antihypertensive Drugs: Potassium-Sparing Diuretics
582
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
582
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Regulation of Sodium and Potassium
554
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
554
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
654
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
654


